BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38516446)

  • 1. A Case of Severe Proton Pump Inhibitor-Induced Hypomagnesemia Refractory to Continuous Oral and Intravenous Magnesium Replenishment.
    Kheir K; Al Jassem O; El Koubayati G; Haddad F
    Cureus; 2024 Feb; 16(2):e54483. PubMed ID: 38516446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
    Semb S; Helgstrand F; Hjørne F; Bytzer P
    World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prolonged omeprazole administration on segmental intestinal Mg
    Suksridechacin N; Kulwong P; Chamniansawat S; Thongon N
    World J Gastroenterol; 2020 Mar; 26(11):1142-1155. PubMed ID: 32231419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review: hypomagnesaemia induced by proton pump inhibition.
    Hess MW; Hoenderop JG; Bindels RJ; Drenth JP
    Aliment Pharmacol Ther; 2012 Sep; 36(5):405-13. PubMed ID: 22762246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of proton pump inhibitor-induced hypomagnesemia.
    Gommers LMM; Hoenderop JGJ; de Baaij JHF
    Acta Physiol (Oxf); 2022 Aug; 235(4):e13846. PubMed ID: 35652564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.
    Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP
    Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: Case reports with a mini-review of the literature.
    Souza CC; Rigueto LG; Santiago HC; Seguro AC; Girardi AC; Luchi WM
    Clin Nephrol Case Stud; 2024; 12():6-11. PubMed ID: 38222324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypomagnesemia.
    Ayuk J; Gittoes NJ
    Am J Kidney Dis; 2014 Apr; 63(4):691-5. PubMed ID: 24100128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.
    dos Santos LM; Guerra RA; Lazaretti-Castro M; Vieira JG; Portes Ede S; Dias-da-Silva MR
    Magnes Res; 2015 Dec; 28(4):136-45. PubMed ID: 26878253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia.
    Tai YT; Tong CV
    J ASEAN Fed Endocr Soc; 2020; 35(1):109-113. PubMed ID: 33442177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes.
    Lazzerini PE; Bertolozzi I; Finizola F; Acampa M; Natale M; Vanni F; Fulceri R; Gamberucci A; Rossi M; Giabbani B; Caselli M; Lamberti I; Cevenini G; Laghi-Pasini F; Capecchi PL
    Front Pharmacol; 2018; 9():363. PubMed ID: 29731714
    [No Abstract]   [Full Text] [Related]  

  • 14. Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms.
    William JH; Danziger J
    World J Nephrol; 2016 Mar; 5(2):152-7. PubMed ID: 26981439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.
    Furlanetto TW; Faulhaber GA
    Arch Intern Med; 2011 Aug; 171(15):1391-2. PubMed ID: 21555654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor-induced hypomagnesemia: A new challenge.
    Florentin M; Elisaf MS
    World J Nephrol; 2012 Dec; 1(6):151-4. PubMed ID: 24175253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe hypomagnesaemia due to proton pump inhibitor use].
    van den Berg S; Scheer MLJ; Holman ND
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    Hughes J; Y Y Chiu D; Kalra PA; Green D
    PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomagnesemia in the intensive care unit: Choosing your gastrointestinal prophylaxis, a case report and review of the literature.
    Wang AK; Sharma S; Kim P; Mrejen-Shakin K
    Indian J Crit Care Med; 2014 Jul; 18(7):456-60. PubMed ID: 25097359
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.